BMRN Financial Facts

Total operating expenses: 339.98M
NET INCOME (LOSS): -42.8M
See Full Income Statement

Convertible debt: 653.18M
Accumulated deficit: -1.57B
See Full Balance Sheet

BioMarin Pharmaceutical Inc. (BMRN) Earnings

  |   Expand Research on BMRN
Next EPS Date 11/5/21 *Est. EPS Growth Rate +143.8% *Last Qtr.
Average EPS % Beat Rate +181.9% Revenue Growth Rate +16.7% *Last Qtr.
Average % Move 1-Wk after EPS -2.3% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
7/28/21 Q221 $0.07-$0.11 +$0.18$501.7M$448.79M = Details
4/29/21 Q121 $0.09-$0.10 +$0.19$486M$446.45M = Details
2/25/21 Q420 $0.12-$0.19 +$0.31$452.1M$440.23M = Details
11/5/20 Q320 $4.01$1.29 +$2.72$476.8M$454.64M = Details
8/4/20 Q220 -$0.16-$0.11 -$0.05$430M$418.61M = Details
4/29/20 Q120 $0.44$0.05 +$0.39$502.1M$468.77M = Details
2/26/20 Q419 $0.08-$0.09 +$0.17$454.4M$459.33M = Details
10/23/19 Q319 $0.30$0.06 +$0.24$461.1M$454.55M = Details